This young man, Tye, is very brave. He is a pioneer in the the Calimmune trial. He was treated approximately 7 months ago. He is part of the the first cohort treated with Calimmune's CAL-1 therapy. This means that he did not receive the busulfan pretreatment at all. Calimmune believes that the busulfan pretreatment will prove helpful.